| Naloxegol 12.5 mg tablet |
| Company |
Formulation ID |
FDA Description |
|
AstraZeneca
|
F14852
|
Magnesium stearate; Mannitol; Propyl gallate; Ferric oxide red; Ferrosoferric oxide; Titanium dioxide; Water; Croscarmellose sodium; Polyethylene glycol 400; Cellulose, microcrystalline; Hypromelloses |
| ------------------------------------------------------------------------------------ |
|
|
|
| Naloxegol 25 mg tablet |
| Company |
Formulation ID |
FDA Description |
|
AstraZeneca; Avera McKennan Hospital; Lake Eire Medical & Surgical Supply DBA Quality Care Products
|
F14853
|
Magnesium stearate; Mannitol; Propyl gallate; Ferric oxide red; Ferrosoferric oxide; Titanium dioxide; Water; Croscarmellose sodium; Polyethylene glycol 400; Cellulose, microcrystalline; Hypromelloses |
| ------------------------------------------------------------------------------------ |
|
|
|
| Naloxegol Oxalate eq 12.5mg base tablet |
| Company |
Formulation ID |
FDA Description |
|
Redhill
|
F23971
|
Mannitol; Cellulose Microcrystalline; Croscarmellose Sodium; Magnesium Stearate; Propyl Gallate; Hypromellose; Titanium Dioxide; Polyethylene Glycol; Iron Oxide Red; Iron Oxide Black |
| ------------------------------------------------------------------------------------ |
|
|
|
| Naloxegol Oxalate eq 25mg base tablet |
| Company |
Formulation ID |
FDA Description |
|
Redhill
|
F23972
|
Mannitol; Cellulose Microcrystalline; Croscarmellose Sodium; Magnesium Stearate; Propyl Gallate; Hypromellose; Titanium Dioxide; Polyethylene Glycol; Iron Oxide Red; Iron Oxide Black |
| ------------------------------------------------------------------------------------ |
|
|
|